Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Tomography (Ann Arbor, Mich.)|August 28, 2024
Magnetic Resonance Imaging and 99Tc WBC-SPECT/CT Scanning in Differential Diagnosis between Osteomyelitis and Charcot Neuroarthropathy: A Case SeriesSara Cecchini, Cristina Gatti, Daniela Fornarelli, et al.
Expert Review of Anticancer Therapy|August 23, 2014
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?Christian Rolfo, Giovanni Sortino, Evelien Smits, et al.
Frontiers in Cell and Developmental Biology|December 17, 2021
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic EffectsSara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
EGFR genomic alterations in cancer: prognostic and predictive valuesGiuseppe Bronte, Marianna Terrasi, Sergio Rizzo, et al.
Expert Opinion on Pharmacotherapy|March 25, 2017
Sorafenib for the treatment of breast cancerGiuseppe Bronte, Daniele Andreis, Sara Bravaccini, et al.
Biomedicines|October 23, 2021
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life ExperiencePaola Ulivi, Elisabetta Petracci, Matteo Canale, et al.
Oncotarget|October 3, 2015
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatmentEnrico Bronte, Giuseppe Bronte, Giuseppina Novo, et al.
Critical Reviews in Oncology/Hematology|November 26, 2015
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinomaFabrizio Bronte, Giuseppe Bronte, Daniele Fanale, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?Giuseppe Bronte, Lorena Incorvaia, Sergio Rizzo, et al.
Expert Review of Anticancer Therapy|December 16, 2014
Cancer and the microbiome: potential applications as new tumor biomarkerKhan Shahanavaj, Ignacio Gil-Bazo, Marta Castiglia, et al.
Pageof 11